Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Sensory neuronopathy: finding the best disease scales for tracking progression

Official title: Clinical Evaluation of Sensory Neuronopathies: the Neuronoscore Study

Run by Centre Hospitalier Universitaire de Saint Etienne · NCT07651540 · Data updated 2026-11-12

This study tests which clinical scales best measure disease severity and progression in adults with sensory neuronopathy.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment70 (estimated)
SponsorCentre Hospitalier Universitaire de Saint Etienne
Academic / other
Drugs / interventionsChemotherapy
Locations19 sites (Angers and 18 other locations)
StatusRecruiting
StartedJuly 6, 2026
Main results expectedJune 25, 2028
Study endsJune 25, 2028
Registry record updatedJuly 10, 2026
Trial IDNCT07651540 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with probable sensory neuronopathy due to specified etiologies, able to read French, and affiliated with a social security system.

Probably not a fit

Patients with non-SN neuropathies or those unable to participate in serial assessments may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study monitors changes in clinical assessment scores over time in people with sensory neuronopathy to identify the most suitable tool for tracking progression. The goal is to determine a SN-specific or SN-appropriate scale that can reliably reflect disability and treatment response. Participants are adults diagnosed with probable SN and followed across several centers in France to compare available scales. The study emphasizes longitudinal scoring rather than a new drug intervention. No biomarker validation is described, focusing instead on scale performance and feasibility.

Why it matters

Potential benefit: If successful, patients may receive more accurate and meaningful measurements of their disease course, guiding care decisions.

How similar studies have gone: Previous SN-specific scales exist but have limited validation; this study explores their applicability in larger populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient affiliated with or beneficiary of a social security system
* Patient having received appropriate study information
* Adult patient ≥18 years old, male or female
* Patient diagnosed with probable SN according to Camdessanché et al. diagnostic criteria
* SN with one of the following etiologies:

Paraneoplastic SN with anti-Hu or anti-CV2/CRMP5 antibodies SN associated with Sjögren's syndrome, systemic lupus erythematosus, or primary biliary cholangitis Platinum-salt-induced SN SN caused by CANVAS syndrome

Exclusion Criteria:

* Patient unable to understand or read French
* Patient refusal to participate
* Patient known to have another neuropathy phenotype and/or etiology that could significantly influence clinical scales and electrophysiological parameters, including:

  * Diabetes mellitus
  * Significant alcohol consumption
  * Severe chronic kidney disease (GFR \<30 ml/min)
  * Vitamin B12 and/or vitamin E deficiency
  * Vitamin B6 excess
  * Chemotherapy other than platinum salts
  * HIV infection

Where it's running

  • Chu de Saint-Etienne
    Saint-Etienne, France
    Recruiting
  • Chu D Angers
    Angers, France
    Not yet recruiting
  • Chu de Clermont Ferrand
    Clermont-Ferrand, France
    Not yet recruiting
  • Chu de Grenoble
    Grenoble, France
    Not yet recruiting
  • Chu de Lille
    Lille, France
    Not yet recruiting
  • Chu de Limoges
    Limoges, France
    Not yet recruiting
Show 13 more locations
  • Hospices Civils de Lyon
    Lyon, France
    Not yet recruiting
  • Hopitaux Universitaire de Marseille
    Marseille, France
    Not yet recruiting
  • Chu de Nancy
    Nancy, France
    Not yet recruiting
  • Chu de Nantes
    Nantes, France
    Not yet recruiting
  • Chu de Nice
    Nice, France
    Not yet recruiting
  • Hopital, Bicetre
    Paris, France
    Not yet recruiting
  • CHU St Etienne
    Saint-Etienne, France
    Not yet recruiting
  • Chu de La Reunion
    Saint-Pierre, France
    Not yet recruiting
  • Hopitaux Universitaire de Strasbourg
    Strasbourg, France
    Not yet recruiting
  • Chu de Toulouse
    Toulouse, France
    Not yet recruiting
  • Hopitaux Universitaire de Geneve
    Geneva, Switzerland
    Not yet recruiting
  • Chuv Centre Hospitalier Vaudois
    Lausanne, Switzerland
    Not yet recruiting
  • Hopital de Sion
    Sion, Switzerland
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.